Glaucoma 360—the annual three-day event held by the Glaucoma Research Foundation (GRF)—will be held again in San Francisco in 2018, from Thursday, Feb. 8, to Saturday, Feb. 10, at the Palace Hotel.
This meeting includes a celebratory gala, a day focused on innovation, and a day of continuing medical education for ophthalmologists and optometrists.
“We like to say that we celebrate, we innovate, and then we educate,” said Thomas Brunner, who is the foundation’s president and chief executive officer (CEO).
Attendees can participate all three days or only attend one or two, as their availability and interest allow.
Ophthalmology Times is a sponsor for the event.
Andrew Iwach, MD, co-chairman for Glaucoma 360, noted that the meeting continues to grow each year, drawing those interested in glaucoma innovation, as well as clinicians who are seeking to learn the newest information to benefit their patients.
“The meeting appears to be resonating with our colleagues because we have identified a need and we are able to provide a platform for open, frank discussions about where we are and what are the next steps that are needed,” Dr. Iwach said. “We are driven by a commitment to find solutions to help patients suffering from glaucoma today, while ultimately trying to find a cure.”
He noted one of the biggest challenges in glaucoma care today is that most interventions will give symptoms to a patient who previously did not have any. This makes it even more important to find new solutions that save vision without having a major detrimental impact on patients’ immediate quality of life.
He noted the field of glaucoma has grown dramatically over the years since Glaucoma 360 began. For example, microinvasive glaucoma surgery (MIGS) had not been approved in the United States when it started.
“We are pleased to be a resource for the community to help move things along,” he said.